UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May14, 2012
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
| Florida | 0-11102 | 59-1564329 |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | I.R.S. Employer Identification No.) |
| 4041 S.W. 47 Avenue, Fort Lauderdale, Florida | 33314 |
| (Address of principal executive offices) | (Zip Code) |
(954) 587-6280
Registrant’s telephone number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On May 9, 2012, Ocean Bio-Chem, Inc. (the “Company”) granted stock awards to each of its named executive officers (as listed in the proxy statement for its 2012 Annual Meeting of Shareholders), as set forth in the following table:
|
Name and Position |
Number
of Shares | |
|
Peter G. Dornau Chairman of the Board, President and Chief Executive Officer
|
15,000 | |
|
Gregor M. Dornau Vice President - Sales & Marketing
|
15,000 | |
|
Jeffrey S. Barocas Vice President-Finance and Chief Financial Officer
|
16,000 | |
|
William W. Dudman Vice President – Operations and Secretary
|
15,000 |
All stock awards vested immediately upon grant. The stock awards were issued under the Ocean Bio-Chem, Inc. Omnibus Equity Compensation Plan
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
May 15, 2012
| Ocean Bio-Chem, Inc. | ||
| By: | /s/ Jeffrey S. Barocas | |
Jeffrey S. Barocas Vice President-Finance and Chief Financial Officer | ||
| 3 |